Biontech stock.

BioNTech expects to release third-quarter results on Nov. 6. BioNTech's stock has dropped 31.1% year to date through Friday, while Pfizer shares have tumbled 37.3% and the S&P 500 has gained 12.7% ...Cash Amount. Record Date. Pay Date. Jun 2, 2022. $2.111. Jun 3, 2022. Jun 17, 2022. * Dividend amounts are adjusted for stock splits when applicable. Get the latest dividend data for BioNTech SE (BNTX), including dividend history, yield, key dates, growth and other metrics.A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.BioNTech and Pfizer's COVID-19 vaccine, COMIRNATY, generated $36.8 billion in sales in 2021, making it the highest-selling pharmaceutical product in a single year. BioNTech's stock has faced ...

BioNTech SE - ADR (22UA) Stock Price & News - Google Finance. Home 22UA • FRA. BioNTech SE - ADR. €83.05. Apr 30, 11:00:14 PM GMT+2 · EUR · FRA · Disclaimer. …BioNTech: The Novavax Fork In The Road. A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

BioNTech (BNTX) to Report Q2 Earnings: What's in the Cards? Why BioNTech Stock Soared 66% in March While the Market Plunged Nasdaq. If You Invested $10,000 in ...Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.5, a high estimate of $171.00, and a low estimate of $99.00. This current average has decreased by ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.BioNTech SE (/ b iː ˈ ɒ n t ɛ k / bee-ON-tek; or / b aɪ ˈ ɒ n t ɛ k / bye-ON-tek short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger …Shares traded 424.39k. 1 Year change -19.68% Beta 0.2477. Data delayed at least 15 minutes, as of May 01 2024 21:00 BST. Find More Stocks. Use our equities screener to …See the company profile for BioNTech SE (BNTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...

Stock Price Statistics The stock price has decreased by -14.48% in the last 52 weeks. The beta is 0.26, so BioNTech SE's price volatility has been lower than the market average.

Mar. 20, 2024 7:05 AM ET BioNTech SE (BNTX) Stock, PFE Stock By: Dulan Lokuwithana, SA News Editor 9 Comments. BioNTech ( NASDAQ: BNTX ), the partner of Pfizer ( NYSE: PFE) for Comirnaty COVID-19 ...

DIS The Walt Disney Company. 105.35. -0.45%. Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your stock trading and investing.Apr 17, 2024 · 1:00a Barron's Buy U.S. Steel Stock. It Won’t Be Stuck in Deal Limbo Forever. ... BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases ... BioNTech Q3 Profit Falls, Trims FY23 Vaccine Revenue Outlook. RTTNews. Nov. 6, 2023, 08:06 AM. (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Nov 6, 2023 ... Secretive German billionaire twins cut Covid vaccine bet after banking 550% gain ... The shares of vaccine maker BioNTech have lost some value.Historical daily share price chart and data for BioNTech SE since 2019 adjusted for splits and dividends. The latest closing stock price for BioNTech SE as ...

4.2100. -5.61%. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Why BioNTech Was a Sickly Stock This Week. Eric Volkman | Dec 30, 2022 The world is trying hard to get past the coronavirus pandemic, and investors are trying hard to get past coronavirus stocks.Answering this question will take us one step closer to our new normal. We know that the vaccines now available across the world will protect their recipients from getting sick wit...MAINZ, Germany, and ROCKVILLE, Maryland, USA, June 29, 2023 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”) today announced that the first patient with non-small cell lung cancer (NSCLC) has been treated in a pivotal Phase 3 trial evaluating the companies’ next-generation anti-CTLA-4 …BioNTech's stock has underperformed the broader market as it is off 27% in the last year compared to the SP500 being up 32%. StockCharts.com. Per Fintel, BioNTech's short interest makes up 3.38% ...BioNTech shares have soared 171.6% year to date through Friday and Pfizer's stock has lost 7.1%, while the S&P 500 SPX, -0.14% has gained 8.6%. Advertisement Read Next

The average 12-month price target for BioNTech stock right now is $261.95, roughly 25% lower than the current share price. That average is based on Refinitiv's survey of 12 analysts.

BioNTech SE (BNTX) is a publicly traded biotechnology business based in the US. It opened the day at $92.56 after a previous close of $91.67. During the day the price has varied from a low of $92.4132 to a high of $93.48. The latest price was $92.72 (25 minute delay). BioNTech is listed on the NASDAQ and employs 6,133 staff.BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June …View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.BioNTech (ADRs) Stock , BNTX. 90.87 -2.56 -2.74% 03:59:59 PM. BTT. Add to watchlist. News. Analyst Data. Analyst Opinions. Insider Activity. Dividend Calendar. . intraday. …Track BioNTech SE - ADR (BNTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAdvertisement. Shares of Pfizer and BioNTech surged on Monday after the FDA officially approved their COVID-19 vaccine. Pfizer jumped as much as 5% to near record highs, while BioNTech was up as ...According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...

NASDAQ: BNTX. BioNTech Se. Market Cap. $22B. Today's Change. (-0.44%) -$0.41. Current Price. $92.31. Price as of May 6, 2024, 10:51 a.m. ET. Or is it too …

BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

BioNTech's stock has underperformed the broader market as it is off 27% in the last year compared to the SP500 being up 32%. StockCharts.com. Per Fintel, BioNTech's short interest makes up 3.38% ...A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.While BioNTech’s has no need to beg investors for more capital, the company will still have to navigate expectations of shareholders who bought it as a Covid stock. Shares in BioNTech have ...Mar 20, 2024 · The high end of the outlook lagged BioNTech stock analysts' forecast for $3.37 billion, according to FactSet. In response, BioNTech stock dropped to its lowest point since January 2021 ... Q1 2024 BioNTech SE Earnings Call. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Stock BNTX BIONTECH SE. PDF Report. Consensus BioNTech SE. Equities. BNTX. US09075V1026. Delayed Nasdaq. Other stock markets. 01:33:33 2024-05-07 pm EDT, 5-day ...Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.About Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. REAL TIME QUOTESAFTER MARKET QUOTES. BioNTech SE ...Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss of 97 cents. The COVID-19 vaccine ...BioNTech plans to initiate a pivotal Phase 2 trial in relapsed/refractory germ cell tumors in 2024. In 2024, BioNTech intends to accelerate the development of its portfolio of next-generation investigational medicines both as monotherapies and in combination with immunotherapy agents and other targeted therapies across a wide range of tumor types.BioNTech SE Sponsored ADR (BNTX) closed at $130.86 in the latest trading session, marking a -1.84% move from the prior day. This change lagged the S&P 500's daily gain of 0.31%.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is ...If BioNTech exercises an option, Autolus will be eligible to receive exercise fees and milestones payments, with low-single digit royalties on net sales of the licensed products. About BioNTech’s cell and gene therapy portfolio BioNTech has been active in the development of cell and gene therapies since 2009.BioNTech hit its lowest point in the month on Feb. 24 at $138.57. The stock has a 52-week low of $90.29 and a 52-week high of $464. Over the past 12 months, the stock is up more than 43%.80.90%. -16.75%. -163.26%. -35.78%. -95.66%. Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for BioNTech SE (BNTX). See many years of revenue, expenses and profits or losses.Instagram:https://instagram. caloosa covetraduccion en vozphilly art museumtattoo font design generator Cash Amount. Record Date. Pay Date. Jun 2, 2022. $2.111. Jun 3, 2022. Jun 17, 2022. * Dividend amounts are adjusted for stock splits when applicable. Get the latest dividend data for BioNTech SE (BNTX), including dividend history, yield, key dates, growth and other metrics. movies tv channelerase cookies on iphone The 12-month price targets, analyzed by analysts, offer insights with an average target of $116.6, a high estimate of $133.00, and a low estimate of $99.00. Experiencing a 11.83% decline, the ...Mar 27, 2023 ... Following the news, BioNTech's stock was down 6% in early trading Monday morning ... BioNTech's share of profits in Pfizer and Fosun Pharma ... craftsman building craft Stock analysis for BioNTech SE (22UA:Xetra) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BNTX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN.